849550-05-6,MFCD09832720
Catalog No.:AA00G3O4

849550-05-6 | 5-Chloro-6-[2,6-difluoro-4-[3-(methylamino)propoxy]phenyl]-N-((1S)-2,2,2-trifluoro-1-methylethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
≥98%
in stock  
$133.00   $93.00
- +
10mg
≥98%
in stock  
$238.00   $166.00
- +
25mg
≥98%
in stock  
$426.00   $298.00
- +
50mg
≥98%
in stock  
$782.00   $547.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00G3O4
Chemical Name:
5-Chloro-6-[2,6-difluoro-4-[3-(methylamino)propoxy]phenyl]-N-((1S)-2,2,2-trifluoro-1-methylethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine
CAS Number:
849550-05-6
Molecular Formula:
C18H18ClF5N6O
Molecular Weight:
464.8201
MDL Number:
MFCD09832720
SMILES:
CNCCCOc1cc(F)c(c(c1)F)c1c(Cl)nc2n(c1N[C@H](C(F)(F)F)C)ncn2
Properties
Computed Properties
 
Complexity:
566  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Heavy Atom Count:
31  
Hydrogen Bond Acceptor Count:
11  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
8  
XLogP3:
4.6  

Literature

Title: A phase I dose escalation study of TTI-237 in patients with advanced malignant solid tumors.

Journal: Investigational new drugs 20120201

Title: The microtubule-active antitumor compound TTI-237 has both paclitaxel-like and vincristine-like properties.

Journal: Cancer chemotherapy and pharmacology 20090901

Title: Cevipabulin (TTI-237): preclinical and clinical results for a novel antimicrotubule agent.

Journal: Methods and findings in experimental and clinical pharmacology 20090901

Title: TTI-237: a novel microtubule-active compound with in vivo antitumor activity.

Journal: Cancer research 20080401

Title: 2-cyanoaminopyrimidines as a class of antitumor agents that promote tubulin polymerization.

Journal: Bioorganic & medicinal chemistry letters 20070601

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 849550-05-6
Tags:849550-05-6 Molecular Formula|849550-05-6 MDL|849550-05-6 SMILES|849550-05-6 5-Chloro-6-[2,6-difluoro-4-[3-(methylamino)propoxy]phenyl]-N-((1S)-2,2,2-trifluoro-1-methylethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine
Catalog No.: AA00G3O4
849550-05-6,MFCD09832720
849550-05-6 | 5-Chloro-6-[2,6-difluoro-4-[3-(methylamino)propoxy]phenyl]-N-((1S)-2,2,2-trifluoro-1-methylethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine
Pack Size: 5mg
Purity: ≥98%
in stock
$133.00 $93.00
Pack Size: 10mg
Purity: ≥98%
in stock
$238.00 $166.00
Pack Size: 25mg
Purity: ≥98%
in stock
$426.00 $298.00
Pack Size: 50mg
Purity: ≥98%
in stock
$782.00 $547.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00G3O4
Chemical Name: 5-Chloro-6-[2,6-difluoro-4-[3-(methylamino)propoxy]phenyl]-N-((1S)-2,2,2-trifluoro-1-methylethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine
CAS Number: 849550-05-6
Molecular Formula: C18H18ClF5N6O
Molecular Weight: 464.8201
MDL Number: MFCD09832720
SMILES: CNCCCOc1cc(F)c(c(c1)F)c1c(Cl)nc2n(c1N[C@H](C(F)(F)F)C)ncn2
Properties
Complexity: 566  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 1  
Heavy Atom Count: 31  
Hydrogen Bond Acceptor Count: 11  
Hydrogen Bond Donor Count: 2  
Rotatable Bond Count: 8  
XLogP3: 4.6  
Literature fold

Title: A phase I dose escalation study of TTI-237 in patients with advanced malignant solid tumors.

Journal: Investigational new drugs20120201

Title: The microtubule-active antitumor compound TTI-237 has both paclitaxel-like and vincristine-like properties.

Journal: Cancer chemotherapy and pharmacology20090901

Title: Cevipabulin (TTI-237): preclinical and clinical results for a novel antimicrotubule agent.

Journal: Methods and findings in experimental and clinical pharmacology20090901

Title: TTI-237: a novel microtubule-active compound with in vivo antitumor activity.

Journal: Cancer research20080401

Title: 2-cyanoaminopyrimidines as a class of antitumor agents that promote tubulin polymerization.

Journal: Bioorganic & medicinal chemistry letters20070601

Building Blocks More >
851879-26-0
851879-26-0
1-[1-(DIFLUOROMETHYL)-1H-BENZIMIDAZOL-2-YL]ETHANOL
AA00G3S1 | MFCD06660529
85072-44-2
85072-44-2
1-Bromo-4-chloro-2,5-dimethylbenzene
AA00G3XP | MFCD07780643
78676-34-3
78676-34-3
1-Benzothiophene-3-carbohydrazide
AA00G44W | MFCD02177147
84752-35-2
84752-35-2
Ethyl 5-hydroxy-2,2-dimethyl-3-oxopentanoate
AA00G4GK | MFCD14702878
817172-31-9
817172-31-9
3-(tert-Butyl)-1-methyl-4-nitro-1H-pyrazole-5-carbaldehyde
AA00G4LW | MFCD03788954
83873-17-0
83873-17-0
(9β,11β)-EpoxyFluorometholoneAcetate
AA00G4ST | MFCD31561987
855473-51-7
855473-51-7
Montelukast Methyl Ester
AA00G4ZA | MFCD29079110
82993-43-9
82993-43-9
LewisYtetrasaccharide
AA00G57A | MFCD00797615
853910-00-6
853910-00-6
2-Fluoro-4-nitrophenylacetonitrile
AA00G5K1 | MFCD13185637
81836-43-3
81836-43-3
m-PEG5-acid
AA00G6SF | MFCD20926398
Submit
© 2017 AA BLOCKS, INC. All rights reserved.